RHI Magnesita, the leading global supplier of high-grade refractory products, systems and solutions, is pleased to announce the completion of the acquisition of the US-based Resco Group, from an ...

Drawing on 35 years of experience in the development and production of high-temperature ceramic fibre, RATH is always looking ...

Bristol Myers Squibb Receives Positive CHMP Opinion for CAR T Cell Therapy Breyanzi for Relapsed or Refractory Follicular Lymphoma ...

VIENNA - RHI Magnesita, the leading global supplier of refractory products, systems, and services, has announced the completion of its acquisition of Resco Products Inc., a US-based refractory ...

Balmoral Funds has sold Resco Group, a Pittsburgh-based producer of shaped and unshaped refractories, to RHI Magnesita, a supplier of refractory products, systems and solutions, for $410 million. This ...

The committee reviewed data showing a 94 percent complete response rate as a third- or later-line treatment for refractory follicular lymphoma.

incorporated in the year 1977, is a Small Cap company (having a market cap of Rs 97.12 Crore) operating in Industrial Consumables sector. Nilachal Refractories Ltd. key Products/Revenue Segments ...

RHI Magnesita India Ltd. key Products/Revenue Segments include Refractories, Income From Management Services, Sale of services and Other Operating Revenue for the year ending 31-Mar-2024.For the ...

Bristol Myers (BMY) announced the Committee for Medicinal Products for Human Use, or CHMP, of the European Medicines Agency, or EMA, has ...